Million Veteran Program Return of Actionable Results
NCT04178122 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 112
Last updated 2025-10-16
Summary
The purpose of the Million Veteran Program- Return of Actionable Results (MVP-ROAR) Study is to develop a process to return medically actionable genetic results to living MVP participants nationwide and to determine the impact of doing so on medical management and outcomes and Veteran quality of life.
Conditions
Interventions
- GENETIC
-
Result disclosure
Disclosure of clinically confirmed, medically actionable genetic testing results and post-test genetic counseling session.
Sponsors & Collaborators
-
VA Office of Research and Development
lead FED
Principal Investigators
-
Jason L Vassy, MD MPH · VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 22 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-02-27
- Primary Completion
- 2024-09-08
- Completion
- 2024-09-08
Countries
- United States
Study Locations
More Related Trials
-
Risk and Resilience in Pulmonary Arterial Hypertension and Genetically Susceptible Individuals
NCT05584722 ·Status: RECRUITING
-
Molecular Determinants of Coronaruy Artery Disease
NCT00590291 ·Status: TERMINATED
-
Coronary Obstruction Detection by Molecular Personalized Gene Expression (Corus CAD or ASGES)
NCT01117506 ·Status: COMPLETED
-
GeneBank at the Cleveland Clinic: Molecular Determinants of Coronary Artery Disease
NCT00590200 ·Status: ACTIVE_NOT_RECRUITING
-
Gene-Environment Interactions in Complex Disease
NCT00064506 ·Status: COMPLETED
-
Implementation of Point-of-Care Pharmacogenomic Decision Support Accounting for Minority Disparities
NCT03225820 ·Status: RECRUITING
-
Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Change in Cardiovascular Health
NCT05819814 ·Status: RECRUITING ·Phase: NA
-
Genetic and Phenotypic Characteristics of Mitral Valve Prolapse
NCT03884426 ·Status: UNKNOWN
-
Genetesis Accelerated Registry
NCT05051228 ·Status: SUSPENDED
-
Prospective Phenotyping for Genetic Subtypes of Early-onset Atrial Fibrillation
NCT05190679 ·Status: COMPLETED
-
Genetic Risk Stratification for Primary Prevention of CAD in Men and Pre & Post-menopausal Women
NCT05169840 ·Status: UNKNOWN
-
Vascular Disease Discovery Protocol
NCT03538639 ·Status: RECRUITING
-
Risk Factors of Individuals With Coronary Artery Disease
NCT00260104 ·Status: UNKNOWN
-
Genetic Predictors of Incident Cardiovascular Disease
NCT00035672 ·Status: WITHDRAWN
-
Cardiovascular and Metabolic Sciences Biorepository
NCT06560424 ·Status: RECRUITING
-
Non-interventional Study of Seroprevalence of Pre-existing Antibodies Against Adenovirus-associated Virus Vector (AAV9) and the Progression of Disease in Patients With Plakophilin 2 (PKP2)-Associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
NCT06311708 ·Status: RECRUITING
-
Personalized Medicine Decision-Making in a Virtual Clinical Setting
NCT02108041 ·Status: COMPLETED
-
Risk Burden of Lipoprotein Metabolic Gene Haplotypes
NCT00090441 ·Status: COMPLETED
-
Genetic Epidemiology of Change in CVD Risk Factors
NCT00037440 ·Status: COMPLETED
-
Utility and Effectiveness of Polygenic Risk Scoring (PRS) for Coronary Artery Disease (CAD)
NCT06542432 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
A Study to Identify Differences in Gene Expression in Patients With Bicuspid and Tricuspid Valve Disease
NCT01194362 ·Status: COMPLETED
-
Identification of Genes Predisposing to Atherosclerosis
NCT00059098 ·Status: COMPLETED
-
Markers of Cardiovascular Risk in Patients With Premature Coronary Artery Disease and Treatment
NCT04613167 ·Status: UNKNOWN ·Phase: NA
-
Genetics of Cardiovascular Disease
NCT06253481 ·Status: RECRUITING
-
Genetic Factors in Atherosclerosis
NCT00359307 ·Status: COMPLETED